Charcot Neuroarthropathy — Foot Reconstruction

Foot & AnkleAdvancedCore Procedure

Charcot Neuroarthropathy — Foot Reconstruction

Surgical reconstruction of the Charcot (neuropathic) foot — Eichenholtz staging, superconstruct arthrodesis principles, midfoot and hindfoot deformity correction, exostectomy, fixation strategies, and total-contact casting for the insensate diabetic foot

High-yield overview

Deformity correction and arthrodesis of the Charcot foot using superconstruct principles | advanced

Surgical Imaging

Charcot midfoot beaming reconstruction
Charcot midfoot reconstruction with intramedullary beaming screws, realigning and stabilising the collapsed arch.Credit: AI-generated medical illustration · OrthoVellum
Critical Danger Structures and Exam Traps
Eichenholtz Stage I — Do Not Fuse

The trap: Operating on a hot, swollen, actively fragmenting Charcot foot (Stage I) in the belief that early fixation will prevent deformity progression.

The reality: Bone is actively resorbing and fragmenting. Fixation placed into this substrate pulls out, the arthrodesis bed has no healing capacity, and the surgery converts a manageable collapse into an infected nonunion with hardware failure. Wait for Eichenholtz Stage II to III (clinical cooling, coalescence or consolidation on imaging) before elective reconstruction.

Insensate Wound Breakdown

The problem: The Charcot patient has peripheral neuropathy and cannot feel wound problems. A wound dehiscence that in a sensate foot would cause pain and prompt early review can progress silently to deep infection and osteomyelitis before anyone notices.

Prevention: Meticulous soft tissue handling. Avoid extensive dorsal dissection where the skin is thin and previous ulceration may compromise blood supply. Consider staged procedures (external fixation first, then definitive fusion) in high-risk cases. Weekly wound inspection for the first 4 to 6 weeks post-operatively.

Hardware Prominence and Recurrent Ulcer

The mechanism: Fixation placed on the plantar surface of the midfoot — for example, plantar plates or protruding screw tips — creates a new bony prominence in the insensate foot that can ulcerate post-operatively, the very problem the surgery was meant to eliminate.

Prevention: Place hardware dorsally or laterally wherever possible. If plantar plate fixation is required, countersink fully and ensure no screw or plate edge protrudes below the plantar cortex. Confirm hardware position fluoroscopically before closure. Plan to remove plantar-sided hardware once fusion is confirmed (often at 6 to 9 months).

Nonunion with Hardware Failure

The problem: Charcot bone is osteopenic and biologically poor. Standard screw fixation is often inadequate — screws cut through cancellous bone, plates break under cyclic loading, and the construct fails before fusion is achieved.

Prevention: Apply superconstruct principles. Extend the fusion beyond the Charcot zone. Use intramedullary nails or beaming for axial load-sharing. Supplement plate fixation with multiple points of fixation. Accept prolonged non-weight-bearing for 8 to 12 weeks minimum and often longer. Use bone graft (autograft or BMP) in the arthrodesis bed.

Deep Infection and Osteomyelitis

The risk: Patients with Charcot foot often have pre-existing or recent plantar ulceration with bacterial colonisation of bone, diabetes with impaired immunity and wound healing, and co-existing vascular disease.

Implications: Deep infection rates after Charcot reconstruction are reported up to 30 percent across series. Hardware removal may be required and the fusion is lost. Two-stage procedures (external fixation to stabilise, then delayed definitive fusion after infection control) may be needed. In some cases, infection leads to amputation.

Misdiagnosis — Cellulitis vs Acute Charcot

The trap: A hot, swollen, erythematous diabetic foot is treated as cellulitis with antibiotics when the true diagnosis is acute Charcot neuroarthropathy (Eichenholtz Stage 0 to I). The distinguishing feature is that Charcot produces a painless or only mildly uncomfortable warm swollen foot in an insensate patient, often with a history of prior Charcot episodes. Cellulitis is typically painful.

The fix: Maintain a high index of suspicion. Compare skin temperature with the contralateral foot using a dermal thermometer. MRI shows bone marrow oedema and microfractures in acute Charcot. If clinical Charcot is suspected, immobilise promptly (total-contact cast or removable boot) and obtain MRI — do not just prescribe antibiotics.

Mnemonic

C.H.A.R.C.O.TCHARCOT — Eichenholtz Staging and Assessment

Mnemonic

S.U.P.E.RSUPER — Superconstruct Principles for Charcot Arthrodesis

Mnemonic

O.F.F.L.O.A.DOFFLOAD — Non-Operative Management Principles

Eichenholtz Classification — Staging Determines Timing

The Eichenholtz classification is the foundation for treatment decisions in Charcot neuroarthropathy. Surgery is timed according to the stage.

Stage 0 (prodromal)
Clinical Features
Warm, swollen, erythematous foot. Pain absent or mild. Early inflammatory phase.
Radiographic Features
Normal radiographs or subtle subluxation. Bone scan or MRI shows early marrow oedema.
Treatment Priority
Immobilise immediately. Total-contact cast. Do NOT operate unless acute instability threatens skin integrity.
Stage I (fragmentation)
Clinical Features
Hot, swollen foot. Temperature greater than 2 degrees above contralateral. Joint effusion.
Radiographic Features
Bony fragmentation, subluxation, dislocation. Debris and osseous destruction at involved joints.
Treatment Priority
Non-operative. Continue TCC. Surgery is contraindicated for elective reconstruction. Exception: fracture-dislocation threatening the skin — urgent external fixation.
Stage II (coalescence)
Clinical Features
Cooling of foot. Reduced swelling. Temperature difference diminishing.
Radiographic Features
Absorption of debris. New bone formation. Coalescence of fragments. Joint surfaces beginning to fuse.
Treatment Priority
Consider surgery. Foot is cooling and bone is beginning to consolidate. Elective arthrodesis can be planned for the near term (once temperature normalises).
Stage III (consolidation)
Clinical Features
Normal temperature. Minimal or no swelling. Fixed deformity.
Radiographic Features
Consolidated bone. Remodelled deformity. Stable but malaligned architecture.
Treatment Priority
Surgery indicated if deformity is unbraceable, ulcer over a prominence, or instability present.
Clinical Pearl

Technical Tip: 'I use a dermal infrared thermometer to compare the Charcot foot against the contralateral side. A temperature difference of greater than 2 degrees Celsius signals active inflammation. I do not plan elective reconstruction until the temperature difference is less than 1 degree for two consecutive measurements at least two weeks apart.'

Sanders Anatomic Classification — Pattern Determines Approach

Type 1
Location
Forefoot (MTP joints)
Typical Deformity
Dislocated toes, plantar metatarsal heads
Common Presentation
Metatarsal head ulceration, transfer metatarsalgia
Type 2
Location
Tarsometatarsal (Lisfranc)
Typical Deformity
Rocker-bottom midfoot, medial column collapse
Common Presentation
Plantar midfoot ulcer over the bony prominence
Type 3
Location
Midtarsal (talonavicular, naviculocuneiform)
Typical Deformity
Lateral column collapse, abduction of forefoot
Common Presentation
Lateral foot ulcer, peritalar subluxation
Type 4
Location
Ankle and subtalar
Typical Deformity
Posterior tibial tendon insufficiency, hindfoot valgus, ankle instability
Common Presentation
Medial malleolar or lateral hindfoot ulcer
Type 5
Location
Calcaneus
Typical Deformity
Posterior calcaneal fragmentation, loss of heel height
Common Presentation
Posterior heel ulcer, Achilles tendon dysfunction

Type 2 (TMT/Lisfranc) is the most common pattern and the classic exam case for Charcot reconstruction.


Surgical Indications

Absolute Indications

  • Unbraceable deformity — fixed rocker-bottom or hindfoot deformity that cannot be accommodated in a CROW boot, custom AFO, or total-contact cast
  • Recurrent or non-healing plantar ulcer over a bony prominence despite adequate offloading (at least 3 months of TCC or CROW boot)
  • Deep infection with osteomyelitis in the Charcot foot — requires debridement with or without concurrent stabilisation
  • Acute instability or fracture-dislocation threatening the soft tissues (urgent external fixation in Eichenholtz Stage I)

Relative Indications

  • Patient declining prolonged non-operative offloading
  • Recurrent ulceration despite brace compliance
  • Progressive deformity on serial radiographs despite immobilisation
  • Inability to wear any footwear due to deformity

Contraindications

Absolute (for elective reconstruction):

  • Eichenholtz Stage I (active fragmentation) — catastrophic failure of fixation and worsening of deformity
  • Uncontrolled infection with systemic sepsis
  • Critical ischaemia (ABI less than 0.45 or absolute toe pressure less than 30 mmHg) without planned revascularisation

Relative:

  • Eichenholtz Stage 0 with no instability — treat non-operatively first
  • HbA1c greater than 10 percent (optimise glycaemic control before elective surgery)
  • Active smoking (increases nonunion and infection risk)
  • End-stage renal disease on dialysis (markedly elevated infection and wound complication rates)
  • Limited ambulatory potential or non-ambulatory patient (amputation may be more appropriate)

Evidence — Non-Operative vs Surgical Management

Total-Contact Casting

  • TCC is the gold-standard non-operative treatment for acute Charcot (Eichenholtz 0 to I) and for offloading plantar ulcers
  • A Cochrane review found TCC more effective than removable cast walkers for healing neuropathic plantar ulcers
  • TCC for acute Charcot: cast changes every 1 to 2 weeks, continue for 8 to 12 weeks, until the foot cools clinically
  • Long-term: transition to CROW boot or custom AFO once the foot is quiescent

Exostectomy

  • Simple resection of a plantar bony prominence without arthrodesis
  • Indicated for an isolated plantar prominence with a non-healing ulcer in a braceable foot
  • Advantage: quick procedure, preserves joint mobility, lower morbidity than arthrodesis
  • Recurrence rate: 30 to 50 percent at 2 to 3 years if the underlying deformity is not corrected — the prominence reforms because the deformity persists

Arthrodesis with Deformity Correction

  • The definitive procedure for unbraceable Charcot deformity
  • Midfoot (TMT) arthrodesis: corrects rocker-bottom, eliminates plantar prominence, provides a stable plantigrade foot
  • Hindfoot (tibiotalocalcaneal) arthrodesis: corrects valgus or varus hindfoot deformity
  • Ankle arthrodesis: for Charcot ankle destruction
  • Fusion rates reported from 60 to 90 percent depending on the site, fixation method, and Eichenholtz stage at surgery

Exostectomy vs Arthrodesis — Decision Guide


Key Evidence

Evidence

Is the Eichenholtz classification still valid for the diabetic Charcot foot?

Level IV
Chantelau EA, Grützner GSwiss Med Wkly
Clinical implication: Eichenholtz staging is the primary guide for surgical timing — reconstructive arthrodesis should be deferred until Stage II to III.
Source: Swiss Med Wkly 2014;144:w13948
Evidence

Superconstructs in the treatment of Charcot foot deformity: plantar plating, locked plating, and axial screw fixation

Level IV
Sammarco VJFoot Ankle Clin
Clinical implication: Superconstruct principles are the foundation of modern Charcot reconstruction — extend fixation beyond the zone of injury and use the strongest available constructs.
Source: Foot Ankle Clin 2009;14(3):393-407
Evidence

Long-term follow-up in diabetic Charcot feet with spontaneous onset

Level III
Fabrin J, Larsen K, Holstein PEDiabetes Care
Clinical implication: TCC remains first-line for acute Charcot; surgery is indicated only for selected patients whose deformity cannot be managed non-operatively.
Source: Diabetes Care 2000;23(6):796-800
Evidence

Are the Sanders-Frykberg and Brodsky-Trepman Classifications Reliable in Diabetic Charcot Neuroarthropathy?

Level III
Wukich DK, Raspovic K, Liu GT, Van Pelt MD, Lalli T, Chhabra A, Nakonezny P, La Fontaine J, Lavery L, Kim PJJ Foot Ankle Surg
Clinical implication: Sanders classification guides surgical planning — the pattern of Charcot involvement determines the approach, fixation, and extent of arthrodesis.
Source: J Foot Ankle Surg 2021;60(3):432-435
Evidence

Charcot foot reconstruction outcomes: a systematic review

Level III
Ha J, Hester T, Foley R, Reichert ILH, Vas PRJ, Ahluwalia R, Kavarthapu VJ Clin Orthop Trauma
Clinical implication: Charcot reconstruction achieves reasonable fusion and limb-salvage rates but complication rates are substantial — careful patient selection and preoperative optimisation are essential.
Source: J Clin Orthop Trauma 2020;11(3):357-368

Clinical Decision Scenarios

Practise clinical reasoning and management decisions out loud

Viva scenarioAdvanced
Clinical prompt

A 56-year-old man with Type 2 diabetes presents with a 3-month history of a non-healing plantar midfoot ulcer. He has a rocker-bottom deformity of the left foot with a 2 cm ulcer directly beneath the midfoot prominence. Radiographs show collapsed TMT joints with debris and early coalescence. Temperature measurement shows a 0.5-degree difference from the right foot. He has been in a CROW boot for 10 weeks with no improvement. How do you manage him?

Practical approach
This patient has Eichenholtz Stage II Charcot neuroarthropathy with a rocker-bottom deformity and a non-healing ulcer despite adequate offloading in a CROW boot for 10 weeks. The temperature difference of only 0.5 degrees confirms the foot has cooled and the active inflammatory phase has resolved. He now meets the indications for surgical reconstruction: unbraceable deformity (rocker-bottom cannot be accommodated long-term), non-healing ulcer over a bony prominence despite adequate offloading, and Eichenholtz Stage II bone suitable for fixation. **Pre-operative workup**: I would obtain CT for detailed bone stock assessment and hardware planning. MRI to exclude osteomyelitis deep to the ulcer — if osteomyelitis is present, I would stage the procedure with debridement first and definitive fusion after infection clearance. Vascular assessment with ABI and toe pressures. Optimise HbA1c to below 9 percent. Nutritional assessment and smoking cessation. **Surgical plan**: Dorsal longitudinal incision over the second TMT joint (the apex of the rocker-bottom deformity). I would expose the TMT joints, resect the Charcot debris and the plantar prominence that is causing the ulcer. Reduce the medial column to a plantigrade alignment. Fixation: dorsal plate across the second and third TMT joints, medial plate along the first TMT joint, a medial column bolt from the first metatarsal through the medial cuneiform into the navicular, and large-diameter screws across each TMT joint. This extends the fusion beyond the Charcot zone and applies the strongest possible fixation — the superconstruct principle. I would bone graft with autograft from the ipsilateral calcaneus and allograft chips. Excise the ulcer en bloc from the plantar approach and close over a drain. **Post-operative**: Non-weight-bearing below-knee cast for 8 to 12 weeks. Weekly wound inspections. Serial radiographs at 6 and 12 weeks. Transition to CROW boot with progressive weight-bearing once consolidation is seen. Plan for hardware removal of prominent implants at 9 to 12 months once fused. **Consent discussion**: I would explain the deep infection risk (up to 20 to 30 percent), nonunion risk (10 to 40 percent), the possibility that this procedure may not heal and amputation could ultimately be required, and the prolonged recovery (6 months or more before return to full function).
Viva scenarioAdvanced
Clinical prompt

A 62-year-old woman with Type 2 diabetes presents with a 4-week history of a hot, swollen left foot. She noticed swelling after walking through an airport in sandals. She has had diabetes for 18 years with peripheral neuropathy. The left foot is erythematous, swollen, and warm to touch. She says it is not particularly painful. Her GP started oral antibiotics for cellulitis 10 days ago with no improvement. How do you manage this?

Practical approach
This presentation is classic for acute Charcot neuroarthropathy (Eichenholtz Stage 0 to I), NOT cellulitis. The key discriminating features are: (1) the patient has established peripheral neuropathy — she is insensate, (2) the foot is relatively painless despite being dramatically swollen and warm, (3) there is no history of a break in the skin or portal of entry for infection, (4) antibiotics have not improved the condition over 10 days, which argues against cellulitis. **Immediate management**: Stop the antibiotics (they are not treating the correct pathology). Immobilise the left foot urgently in a total-contact cast or at minimum a rigid below-knee boot. The patient must be non-weight-bearing. Even if I cannot distinguish clinically between cellulitis and acute Charcot, the correct response is the same — immobilise and investigate. The danger of missing Charcot is irreversible deformity; the danger of treating Charcot as cellulitis is weeks of unprotected weight-bearing on a fragmenting foot. **Investigation**: I would obtain bilateral foot radiographs — in early Charcot (Stage 0), these may be normal or show only subtle subluxation. MRI is the investigation of choice: it will show bone marrow oedema, microfractures, and periarticular inflammation consistent with Charcot. MRI can also help distinguish Charcot from osteomyelitis, though both produce marrow oedema. If MRI is equivocal, a labelled white-cell scan (indium or Tc99m-HMPAO) can help — infection concentrates labelled white cells, Charcot does not. **Temperature monitoring**: I would measure the skin temperature of both feet using an infrared dermal thermometer. A temperature difference of greater than 2 degrees Celsius from the contralateral side confirms active inflammation. **Long-term management**: Continue TCC for 8 to 12 weeks with weekly cast changes and skin inspection. Transition to CROW boot once the foot cools. Monitor serial radiographs for progression through Eichenholtz stages. Educate the patient that this is a chronic condition — the risk of recurrent Charcot episodes or contralateral involvement is lifelong.
Viva scenarioAdvanced
Clinical prompt

You are asked to see a 60-year-old man with Type 2 diabetes in the orthopaedic clinic. He had a midfoot Charcot reconstruction with TMT arthrodesis 14 months ago at another hospital. Radiographs show solid fusion but there is a new ulcer on the plantar aspect of the foot, just distal to the arthrodesis site. There is a bony prominence visible on the lateral view that was not present on the immediate post-operative films. How do you explain this and manage him?

Practical approach
This patient has recurrent Charcot activation at a joint adjacent to his previous arthrodesis — a recognised complication of Charcot reconstruction. The Charcot neuroarthropathy process can reactivate at joints adjacent to a fusion mass, producing a new area of collapse and deformity. **Explanation**: The Charcot process is driven by the underlying neuropathy and inflammatory cascade, not by the original injury alone. Fusing one region of the foot transfers mechanical stress to adjacent joints, which can trigger a new Charcot episode. This is one of the reasons the superconstruct principle emphasises extending the fusion beyond the zone of injury — the longer the fusion mass, the fewer adjacent joints are at risk. **Assessment**: I would assess the new Charcot activity. Temperature measurement to check for active inflammation. MRI to confirm whether there is active fragmentation at the adjacent joint or whether this is a late presentation of residual deformity from the initial surgery. Check vascular status. Check for osteomyelitis at the new ulcer site. **Management options**: 1. If the new Charcot is active (hot, MRI shows acute fragmentation): immobilise in TCC and treat non-operatively. Once the new episode cools, reassess for deformity and consider extending the fusion. 2. If the foot is quiescent (cooled, consolidation on imaging) but the deformity is unbraceable with a recurrent ulcer: extend the arthrodesis to include the newly involved joints, using the same superconstruct principles. 3. If the ulcer is superficial and the deformity is minor: TCC to heal the ulcer, then CROW boot long-term. Monitor closely for progression. **Long-term implications**: This patient needs lifelong foot surveillance. Every new area of swelling, warmth, or ulceration requires urgent assessment for recurrent Charcot. He should be educated about the risk of contralateral foot involvement and the importance of daily foot checks.
Exam day cheat sheet
Charcot Foot Reconstruction — Exam Day Summary

References

Evidence

Is the Eichenholtz classification still valid for the diabetic Charcot foot?

Level IV
Chantelau EA, Grützner GSwiss Med Wkly
Clinical implication: Eichenholtz staging is the primary guide for surgical timing — reconstructive arthrodesis should be deferred until Stage II to III.
Source: Swiss Med Wkly 2014;144:w13948
Evidence

Superconstructs in the treatment of Charcot foot deformity: plantar plating, locked plating, and axial screw fixation

Level IV
Sammarco VJFoot Ankle Clin
Clinical implication: Superconstruct principles are the foundation of modern Charcot reconstruction — extend fixation beyond the zone of injury and use the strongest available constructs.
Source: Foot Ankle Clin 2009;14(3):393-407
Evidence

Long-term follow-up in diabetic Charcot feet with spontaneous onset

Level III
Fabrin J, Larsen K, Holstein PEDiabetes Care
Clinical implication: TCC remains first-line treatment; surgery is indicated for selected patients whose deformity cannot be managed non-operatively.
Source: Diabetes Care 2000;23(6):796-800
Evidence

Are the Sanders-Frykberg and Brodsky-Trepman Classifications Reliable in Diabetic Charcot Neuroarthropathy?

Level III
Wukich DK, Raspovic K, Liu GT, Van Pelt MD, Lalli T, Chhabra A, Nakonezny P, La Fontaine J, Lavery L, Kim PJJ Foot Ankle Surg
Clinical implication: Sanders classification guides surgical planning — the pattern of Charcot involvement determines the approach, fixation, and extent of arthrodesis.
Source: J Foot Ankle Surg 2021;60(3):432-435
Evidence

Charcot foot reconstruction outcomes: a systematic review

Level III
Ha J, Hester T, Foley R, Reichert ILH, Vas PRJ, Ahluwalia R, Kavarthapu VJ Clin Orthop Trauma
Clinical implication: Charcot reconstruction achieves reasonable fusion and limb-salvage rates but complication rates are substantial — careful patient selection and preoperative optimisation are essential.
Source: J Clin Orthop Trauma 2020;11(3):357-368
Editorially reviewed — transparent references and correction processPublished by OrthoVellum Medical Education TeamEditorial boardMethodologyReview policy
Educational disclosure

Educational content is reviewed for source visibility, editorial coherence, and correction readiness.

No individual clinician credential is claimed unless a named person is shown.

Verify before clinical use; this is not medical advice or a substitute for local guidance.